Reports

Industry Research Reports

Global Pet Euthanasia Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Pet Euthanasia Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-11-16

Pages: 141 Pages

Report ld: 5453726

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Pet Euthanasia Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

7.3%

marketSize

Market Size,2031

USD 314

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 206 million
Market Forecast in 2031(Value)
US$ 314 million
CAGR
7.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Pet Euthanasia market is projected to grow from US$ 193 million in 2024 to US$ 314 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 463%.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pet Euthanasia market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Affiliate of Mars Inc.
  • Ruipeng Pet
  • The Pet Hospitals
  • Pet Hospital of Madison
  • BluePearl Pet Hospital
  • RingPai Pet Hospital
  • Beijing Chong'ai International Animal Hospital
  • MedVet
  • Zoetis
  • AniCura
  • Meilian Zhonghe Animal Hospital
  • Baker and Stone Animal Hospital
  • Abel Pet Hospital
  • PUPPY TOWN ANIMAL HOSPITAL

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Potassium Chloride Injection
  • Oral Sleeping Pills
  • Injection of Coagulant
  • Pentobarbital Injection
  • Injection of Saturated Magnesium Sulfate
  • Others

Segment by Application

  • Pet Hospital
  • Veterinary Clinic
  • Zoo
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Pet Euthanasia study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Pet Euthanasia: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Pet Euthanasia Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Potassium Chloride Injection

1.2.3 Oral Sleeping Pills

1.2.4 Injection of Coagulant

1.2.5 Pentobarbital Injection

1.2.6 Injection of Saturated Magnesium Sulfate

1.2.7 Others

1.3 Market Segmentation by Application

1.3.1 Global Pet Euthanasia Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pet Hospital

1.3.3 Veterinary Clinic

1.3.4 Zoo

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Pet Euthanasia Revenue Estimates and Forecasts 2020-2031

2.2 Global Pet Euthanasia Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

muLu

3 Competition by Players

3.1 Global Pet Euthanasia Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Pet Euthanasia Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Potassium Chloride Injection Market Size by Players

3.3.2 Oral Sleeping Pills Market Size by Players

3.3.3 Injection of Coagulant Market Size by Players

3.3.4 Pentobarbital Injection Market Size by Players

3.3.5 Injection of Saturated Magnesium Sulfate Market Size by Players

3.3.6 Others Market Size by Players

3.4 Global Pet Euthanasia Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global Pet Euthanasia Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global Pet Euthanasia Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

muLu

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Pet Euthanasia Market Size by Type (2020-2031)

6.4 North America Pet Euthanasia Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Pet Euthanasia Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

muLu

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Pet Euthanasia Market Size by Type (2020-2031)

7.4 Europe Pet Euthanasia Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Pet Euthanasia Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Pet Euthanasia Market Size by Type (2020-2031)

8.4 Asia-Pacific Pet Euthanasia Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Pet Euthanasia Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

muLu

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Pet Euthanasia Market Size by Type (2020-2031)

9.4 Central and South America Pet Euthanasia Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Pet Euthanasia Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Pet Euthanasia Market Size by Type (2020-2031)

10.4 Middle East and Africa Pet Euthanasia Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Pet Euthanasia Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Affiliate of Mars Inc.

11.1.1 Affiliate of Mars Inc. Corporation Information

11.1.2 Affiliate of Mars Inc. Business Overview

11.1.3 Affiliate of Mars Inc. Pet Euthanasia Product Features and Attributes

11.1.4 Affiliate of Mars Inc. Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.1.5 Affiliate of Mars Inc. Pet Euthanasia Revenue by Product in 2024

11.1.6 Affiliate of Mars Inc. Pet Euthanasia Revenue by Application in 2024

11.1.7 Affiliate of Mars Inc. Pet Euthanasia Revenue by Geographic Area in 2024

11.1.8 Affiliate of Mars Inc. Pet Euthanasia SWOT Analysis

11.1.9 Affiliate of Mars Inc. Recent Developments

11.2 Ruipeng Pet

11.2.1 Ruipeng Pet Corporation Information

11.2.2 Ruipeng Pet Business Overview

11.2.3 Ruipeng Pet Pet Euthanasia Product Features and Attributes

11.2.4 Ruipeng Pet Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.2.5 Ruipeng Pet Pet Euthanasia Revenue by Product in 2024

11.2.6 Ruipeng Pet Pet Euthanasia Revenue by Application in 2024

11.2.7 Ruipeng Pet Pet Euthanasia Revenue by Geographic Area in 2024

11.2.8 Ruipeng Pet Pet Euthanasia SWOT Analysis

11.2.9 Ruipeng Pet Recent Developments

11.3 The Pet Hospitals

11.3.1 The Pet Hospitals Corporation Information

11.3.2 The Pet Hospitals Business Overview

11.3.3 The Pet Hospitals Pet Euthanasia Product Features and Attributes

11.3.4 The Pet Hospitals Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.3.5 The Pet Hospitals Pet Euthanasia Revenue by Product in 2024

11.3.6 The Pet Hospitals Pet Euthanasia Revenue by Application in 2024

11.3.7 The Pet Hospitals Pet Euthanasia Revenue by Geographic Area in 2024

11.3.8 The Pet Hospitals Pet Euthanasia SWOT Analysis

11.3.9 The Pet Hospitals Recent Developments

11.4 Pet Hospital of Madison

11.4.1 Pet Hospital of Madison Corporation Information

11.4.2 Pet Hospital of Madison Business Overview

11.4.3 Pet Hospital of Madison Pet Euthanasia Product Features and Attributes

11.4.4 Pet Hospital of Madison Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.4.5 Pet Hospital of Madison Pet Euthanasia Revenue by Product in 2024

11.4.6 Pet Hospital of Madison Pet Euthanasia Revenue by Application in 2024

11.4.7 Pet Hospital of Madison Pet Euthanasia Revenue by Geographic Area in 2024

11.4.8 Pet Hospital of Madison Pet Euthanasia SWOT Analysis

11.4.9 Pet Hospital of Madison Recent Developments

11.5 BluePearl Pet Hospital

11.5.1 BluePearl Pet Hospital Corporation Information

11.5.2 BluePearl Pet Hospital Business Overview

11.5.3 BluePearl Pet Hospital Pet Euthanasia Product Features and Attributes

11.5.4 BluePearl Pet Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.5.5 BluePearl Pet Hospital Pet Euthanasia Revenue by Product in 2024

11.5.6 BluePearl Pet Hospital Pet Euthanasia Revenue by Application in 2024

11.5.7 BluePearl Pet Hospital Pet Euthanasia Revenue by Geographic Area in 2024

11.5.8 BluePearl Pet Hospital Pet Euthanasia SWOT Analysis

11.5.9 BluePearl Pet Hospital Recent Developments

11.6 RingPai Pet Hospital

11.6.1 RingPai Pet Hospital Corporation Information

11.6.2 RingPai Pet Hospital Business Overview

11.6.3 RingPai Pet Hospital Pet Euthanasia Product Features and Attributes

11.6.4 RingPai Pet Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.6.5 RingPai Pet Hospital Recent Developments

11.7 Beijing Chong'ai International Animal Hospital

11.7.1 Beijing Chong'ai International Animal Hospital Corporation Information

11.7.2 Beijing Chong'ai International Animal Hospital Business Overview

11.7.3 Beijing Chong'ai International Animal Hospital Pet Euthanasia Product Features and Attributes

11.7.4 Beijing Chong'ai International Animal Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.7.5 Beijing Chong'ai International Animal Hospital Recent Developments

11.8 MedVet

11.8.1 MedVet Corporation Information

11.8.2 MedVet Business Overview

11.8.3 MedVet Pet Euthanasia Product Features and Attributes

11.8.4 MedVet Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.8.5 MedVet Recent Developments

11.9 Zoetis

11.9.1 Zoetis Corporation Information

11.9.2 Zoetis Business Overview

11.9.3 Zoetis Pet Euthanasia Product Features and Attributes

11.9.4 Zoetis Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.9.5 Zoetis Recent Developments

11.10 AniCura

11.10.1 AniCura Corporation Information

11.10.2 AniCura Business Overview

11.10.3 AniCura Pet Euthanasia Product Features and Attributes

11.10.4 AniCura Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Meilian Zhonghe Animal Hospital

11.11.1 Meilian Zhonghe Animal Hospital Corporation Information

11.11.2 Meilian Zhonghe Animal Hospital Business Overview

11.11.3 Meilian Zhonghe Animal Hospital Pet Euthanasia Product Features and Attributes

11.11.4 Meilian Zhonghe Animal Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.11.5 Meilian Zhonghe Animal Hospital Recent Developments

11.12 Baker and Stone Animal Hospital

11.12.1 Baker and Stone Animal Hospital Corporation Information

11.12.2 Baker and Stone Animal Hospital Business Overview

11.12.3 Baker and Stone Animal Hospital Pet Euthanasia Product Features and Attributes

11.12.4 Baker and Stone Animal Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.12.5 Baker and Stone Animal Hospital Recent Developments

11.13 Abel Pet Hospital

11.13.1 Abel Pet Hospital Corporation Information

11.13.2 Abel Pet Hospital Business Overview

11.13.3 Abel Pet Hospital Pet Euthanasia Product Features and Attributes

11.13.4 Abel Pet Hospital Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.13.5 Abel Pet Hospital Recent Developments

11.14 PUPPY TOWN ANIMAL HOSPITAL

11.14.1 PUPPY TOWN ANIMAL HOSPITAL Corporation Information

11.14.2 PUPPY TOWN ANIMAL HOSPITAL Business Overview

11.14.3 PUPPY TOWN ANIMAL HOSPITAL Pet Euthanasia Product Features and Attributes

11.14.4 PUPPY TOWN ANIMAL HOSPITAL Pet Euthanasia Revenue and Gross Margin (2020-2025)

11.14.5 PUPPY TOWN ANIMAL HOSPITAL Recent Developments

muLu

12 Pet EuthanasiaIndustry Chain Analysis

12.1 Pet Euthanasia Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Pet Euthanasia Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global Pet Euthanasia Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Pet Euthanasia Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pet Euthanasia Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pet Euthanasia Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pet Euthanasia Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pet Euthanasia Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pet Euthanasia Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pet Euthanasia Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pet Euthanasia by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Euthanasia as of 2024)
Table 11. Global Pet Euthanasia Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pet Euthanasia Companies Headquarters
Table 13. Global Pet Euthanasia Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pet Euthanasia Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pet Euthanasia Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pet Euthanasia Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pet Euthanasia Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pet Euthanasia High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pet Euthanasia Growth Accelerators and Market Barriers
Table 25. North America Pet Euthanasia Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pet Euthanasia Growth Accelerators and Market Barriers
Table 27. Europe Pet Euthanasia Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pet Euthanasia Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pet Euthanasia Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pet Euthanasia Investment Opportunities and Key Challenges
Table 31. Central and South America Pet Euthanasia Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pet Euthanasia Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pet Euthanasia Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Affiliate of Mars Inc. Corporation Information
Table 35. Affiliate of Mars Inc. Description and Major Businesses
Table 36. Affiliate of Mars Inc. Product Features and Attributes
Table 37. Affiliate of Mars Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Affiliate of Mars Inc. Revenue Proportion by Product in 2024
Table 39. Affiliate of Mars Inc. Revenue Proportion by Application in 2024
Table 40. Affiliate of Mars Inc. Revenue Proportion by Geographic Area in 2024
Table 41. Affiliate of Mars Inc. Pet Euthanasia SWOT Analysis
Table 42. Affiliate of Mars Inc. Recent Developments
Table 43. Ruipeng Pet Corporation Information
Table 44. Ruipeng Pet Description and Major Businesses
Table 45. Ruipeng Pet Product Features and Attributes
Table 46. Ruipeng Pet Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Ruipeng Pet Revenue Proportion by Product in 2024
Table 48. Ruipeng Pet Revenue Proportion by Application in 2024
Table 49. Ruipeng Pet Revenue Proportion by Geographic Area in 2024
Table 50. Ruipeng Pet Pet Euthanasia SWOT Analysis
Table 51. Ruipeng Pet Recent Developments
Table 52. The Pet Hospitals Corporation Information
Table 53. The Pet Hospitals Description and Major Businesses
Table 54. The Pet Hospitals Product Features and Attributes
Table 55. The Pet Hospitals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. The Pet Hospitals Revenue Proportion by Product in 2024
Table 57. The Pet Hospitals Revenue Proportion by Application in 2024
Table 58. The Pet Hospitals Revenue Proportion by Geographic Area in 2024
Table 59. The Pet Hospitals Pet Euthanasia SWOT Analysis
Table 60. The Pet Hospitals Recent Developments
Table 61. Pet Hospital of Madison Corporation Information
Table 62. Pet Hospital of Madison Description and Major Businesses
Table 63. Pet Hospital of Madison Product Features and Attributes
Table 64. Pet Hospital of Madison Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Pet Hospital of Madison Revenue Proportion by Product in 2024
Table 66. Pet Hospital of Madison Revenue Proportion by Application in 2024
Table 67. Pet Hospital of Madison Revenue Proportion by Geographic Area in 2024
Table 68. Pet Hospital of Madison Pet Euthanasia SWOT Analysis
Table 69. Pet Hospital of Madison Recent Developments
Table 70. BluePearl Pet Hospital Corporation Information
Table 71. BluePearl Pet Hospital Description and Major Businesses
Table 72. BluePearl Pet Hospital Product Features and Attributes
Table 73. BluePearl Pet Hospital Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. BluePearl Pet Hospital Revenue Proportion by Product in 2024
Table 75. BluePearl Pet Hospital Revenue Proportion by Application in 2024
Table 76. BluePearl Pet Hospital Revenue Proportion by Geographic Area in 2024
Table 77. BluePearl Pet Hospital Pet Euthanasia SWOT Analysis
Table 78. BluePearl Pet Hospital Recent Developments
Table 79. RingPai Pet Hospital Corporation Information
Table 80. RingPai Pet Hospital Description and Major Businesses
Table 81. RingPai Pet Hospital Product Features and Attributes
Table 82. RingPai Pet Hospital Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. RingPai Pet Hospital Recent Developments
Table 84. Beijing Chong'ai International Animal Hospital Corporation Information
Table 85. Beijing Chong'ai International Animal Hospital Description and Major Businesses
Table 86. Beijing Chong'ai International Animal Hospital Product Features and Attributes
Table 87. Beijing Chong'ai International Animal Hospital Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Beijing Chong'ai International Animal Hospital Recent Developments
Table 89. MedVet Corporation Information
Table 90. MedVet Description and Major Businesses
Table 91. MedVet Product Features and Attributes
Table 92. MedVet Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. MedVet Recent Developments
Table 94. Zoetis Corporation Information
Table 95. Zoetis Description and Major Businesses
Table 96. Zoetis Product Features and Attributes
Table 97. Zoetis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Zoetis Recent Developments
Table 99. AniCura Corporation Information
Table 100. AniCura Description and Major Businesses
Table 101. AniCura Product Features and Attributes
Table 102. AniCura Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. AniCura Recent Developments
Table 104. Meilian Zhonghe Animal Hospital Corporation Information
Table 105. Meilian Zhonghe Animal Hospital Description and Major Businesses
Table 106. Meilian Zhonghe Animal Hospital Product Features and Attributes
Table 107. Meilian Zhonghe Animal Hospital Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Meilian Zhonghe Animal Hospital Recent Developments
Table 109. Baker and Stone Animal Hospital Corporation Information
Table 110. Baker and Stone Animal Hospital Description and Major Businesses
Table 111. Baker and Stone Animal Hospital Product Features and Attributes
Table 112. Baker and Stone Animal Hospital Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Baker and Stone Animal Hospital Recent Developments
Table 114. Abel Pet Hospital Corporation Information
Table 115. Abel Pet Hospital Description and Major Businesses
Table 116. Abel Pet Hospital Product Features and Attributes
Table 117. Abel Pet Hospital Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Abel Pet Hospital Recent Developments
Table 119. PUPPY TOWN ANIMAL HOSPITAL Corporation Information
Table 120. PUPPY TOWN ANIMAL HOSPITAL Description and Major Businesses
Table 121. PUPPY TOWN ANIMAL HOSPITAL Product Features and Attributes
Table 122. PUPPY TOWN ANIMAL HOSPITAL Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. PUPPY TOWN ANIMAL HOSPITAL Recent Developments
Table 124. Raw Materials Key Suppliers
Table 125. Distributors List
Table 126. Market Trends and Market Evolution
Table 127. Market Drivers and Opportunities
Table 128. Market Challenges, Risks, and Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Pet Euthanasia Product Picture
Figure 2. Global Pet Euthanasia Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Potassium Chloride Injection Product Picture
Figure 4. Oral Sleeping Pills Product Picture
Figure 5. Injection of Coagulant Product Picture
Figure 6. Pentobarbital Injection Product Picture
Figure 7. Injection of Saturated Magnesium Sulfate Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pet Euthanasia Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Pet Hospital
Figure 11. Veterinary Clinic
Figure 12. Zoo
Figure 13. Others
Figure 14. Pet Euthanasia Report Years Considered
Figure 15. Global Pet Euthanasia Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 17. Global Pet Euthanasia Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Pet Euthanasia Revenue Market Share by Region (2020-2031)
Figure 19. Global Pet Euthanasia Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Potassium Chloride Injection Revenue Market Share by Player in 2024
Figure 22. Oral Sleeping Pills Revenue Market Share by Player in 2024
Figure 23. Injection of Coagulant Revenue Market Share by Player in 2024
Figure 24. Pentobarbital Injection Revenue Market Share by Player in 2024
Figure 25. Injection of Saturated Magnesium Sulfate Revenue Market Share by Player in 2024
Figure 26. Others Revenue Market Share by Player in 2024
Figure 27. Global Pet Euthanasia Revenue Market Share by Type (2020-2031)
Figure 28. Global Pet Euthanasia Revenue Market Share by Application (2020-2031)
Figure 29. North America Pet Euthanasia Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Players Pet Euthanasia Revenue (US$ Million) in 2024
Figure 31. North America Pet Euthanasia Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Pet Euthanasia Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Pet Euthanasia Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Players Pet Euthanasia Revenue (US$ Million) in 2024
Figure 38. Europe Pet Euthanasia Revenue (US$ Million) by Type (2020-2031)
Figure 39. Europe Pet Euthanasia Revenue (US$ Million) by Application (2020-2031)
Figure 40. Germany Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 41. France Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 42. U.K. Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 43. Italy Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 44. Russia Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Pet Euthanasia Revenue YoY (2020-2031) & (US$ Million)
Figure 46. Asia-Pacific Top 8 Players Pet Euthanasia Revenue (US$ Million) in 2024
Figure 47. Asia-Pacific Pet Euthanasia Revenue (US$ Million) by Type (2020-2031)
Figure 48. Asia-Pacific Pet Euthanasia Revenue (US$ Million) by Application (2020-2031)
Figure 49. Indonesia Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 50. Japan Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 51. South Korea Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 52. Australia Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 53. India Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 54. Indonesia Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 55. Vietnam Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 56. Malaysia Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 57. Philippines Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 58. Singapore Pet Euthanasia Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Pet Euthanasia Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Central and South America Top 5 Players Pet Euthanasia Revenue (US$ Million) in 2024
Figure 61. Central and South America Pet Euthanasia Revenue (US$ Million) by Type (2020-2031)
Figure 62. Central and South America Pet Euthanasia Revenue (US$ Million) by Application (2020-2031)
Figure 63. Brazil Pet Euthanasia Revenue (2020-2025) & (US$ Million)
Figure 64. Argentina Pet Euthanasia Revenue (2020-2025) & (US$ Million)
Figure 65. Middle East and Africa Pet Euthanasia Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Middle East and Africa Top 5 Players Pet Euthanasia Revenue (US$ Million) in 2024
Figure 67. South America Pet Euthanasia Revenue (US$ Million) by Type (2020-2031)
Figure 68. Middle East and Africa Pet Euthanasia Revenue (US$ Million) by Application (2020-2031)
Figure 69. GCC Countries Pet Euthanasia Revenue (2020-2025) & (US$ Million)
Figure 70. Israel Pet Euthanasia Revenue (2020-2025) & (US$ Million)
Figure 71. Egypt Pet Euthanasia Revenue (2020-2025) & (US$ Million)
Figure 72. South Africa Pet Euthanasia Revenue (2020-2025) & (US$ Million)
Figure 73. Pet Euthanasia Industry Chain Mapping
Figure 74. Channels of Distribution (Direct Vs Distribution)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pet Euthanasia market?zhanKai
The top companies in the global Pet Euthanasia market are Affiliate of Mars Inc.、Ruipeng Pet、The Pet Hospitals.
What is the annual compound growth rate of the global Pet Euthanasia market size from 2025 to 2031?shouQi
What was the global market size of Pet Euthanasia in 2031?shouQi
What was the global market size of Pet Euthanasia in 2025?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Global Pet Euthanasia Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-11-16

Pages: 141 Pages

Report ld: 5453726

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now